Randal S. Weber

46.8k citations

405 papers · 28.7k indexed · 7 hit papers · h-index 78

Otorhinolaryngology top 0.01%
- Head and Neck Cancer Studies 195
Oncology top 0.05%
- Ear and Head Tumors 67
- Cancer Diagnosis and Treatment 40
Surgery top 0.02%
- Salivary Gland Tumors Diagnosis and Treatment 86
- Head and Neck Surgical Oncology 78
Pulmonary and Respiratory Medicine top 0.1%
- Tracheal and airway disorders 32
Oral Surgery top 0.2%
- Oral and Maxillofacial Pathology 34
Epidemiology
- Nonmelanoma Skin Cancer Studies 31

Co-authors: David I. Rosenthal Adam S. Garden K. Kian Ang William H. Morrison Adel K. El‐Naggar Helmuth Goepfert Arlene A. Forastiere Jay S. Cooper
Cited by: Otorhinolaryngology Oncology Surgery
Journals: New England Journal of Medicine (4 papers)Journal of Clinical Oncology (35 papers)SHILAP Revista de lepidopterología (2 papers)
Partner nations: United States Canada Italy

In The Last Decade

Randal S. Weber

396 papers receiving 28.1k citations

Hit Papers

7 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2015 Cancer
2014 Journal of Clinical Oncology
2014 Journal of Clinical Oncology
2012 Journal of Clinical Oncology
2010 New England Journal of Medicine
2008 Journal of Clinical Oncology
2003 New England Journal of Medicine

Peers

Countries citing papers authored by Randal S. Weber

Since Specialization

Citations

This map shows the geographic impact of Randal S. Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randal S. Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randal S. Weber more than expected).

Fields of papers citing papers by Randal S. Weber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randal S. Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randal S. Weber. The network helps show where Randal S. Weber may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Randal S. Weber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Randal S. Weber Line = papers co-authored together Randal S. Weber links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Intestinal-Type Adenocarcinoma in Head and Neck: Dissecting Oncogenic Gene Alterations Through Whole Transcriptome and Exome Analysis Modern Pathology ·Diana Bell,Achim Bell,Randal S. Weber,Ehab Y. Hanna	2023	0
2	Delay to surgery after neoadjuvant chemotherapy in head and neck squamous cell carcinoma affects oncologic outcomes Cancer ·Kimberley L. Kiong,Christopher M. K. L. Yao,Fang‐Yu Lin,Diana Bell,Renata Ferrarotto,Randal S. Weber,Carol M. Lewis	2021	4
3	The tumor immune contexture of salivary duct carcinoma Head & Neck ·Gustavo Schvartsman,Diana Bell,M. Laura Rubin,Michael T. Tetzlaff,Ehab Y. Hanna,J. Jack Lee,Randal S. Weber,Jack Phan,Bonnie S. Glisson,Renata Ferrarotto	2021	10
4	Impact of neoadjuvant chemotherapy on perioperative morbidity after major surgery for head and neck cancer Cancer ·Kimberley L. Kiong,Fang‐Yu Lin,Christopher M. K. L. Yao,Theresa Guo,Renata Ferrarotto,Randal S. Weber,Carol M. Lewis	2020	9
5	Association between postoperative complications and long‐term oncologic outcomes following total laryngectomy: 10‐year experience at MD Anderson Cancer Center Cancer ·Stefanos Boukovalas,Ryan P. Goepfert,Jeffrey M. Smith,Elise M. Mecham,Jun Liu,Mark Zafereo,Edward I. Chang,Amy C. Hessel,Matthew M. Hanasono,Neil D. Gross,Peirong Yu,Jan S. Lewin,Carol M. Lewis,Eduardo M. Diaz,Randal S. Weber,Jeffrey N. Myers,Anaeze C. Offodile	2020	13
6	Incompletely treated malignancies of the major salivary gland: Toward evidence‐based care Head & Neck ·Samantha Tam,Vlad C. Sandulache,Kareem A. Metwalli,Crosby D. Rock,S. Eraj,Tommy Sheu,Adel K. El‐Naggar,Clifton D. Fuller,Randal S. Weber,Stephen Y. Lai	2018	5
7	Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy Cancer ·Pierre Saintigny,Yoshitsugu Mitani,Kristen B. Pytynia,Renata Ferrarotto,Dianna Roberts,Randal S. Weber,Merrill S. Kies,Sankar N. Maity,Sue‐Hwa Lin,Adel K. El‐Naggar	2018	24
8	Nontarget Swallowing Muscles Dose-Volume Correlates of Patient-Reported Outcomes After Oropharyngeal Intensity Modulated Radiation Therapy (IMRT) International Journal of Radiation OncologyBiologyPhysics ·Jay Shiao,Abdallah Mohamed,G. Brandon Gunn,Katherine A. Hutcheson,A. Kanwar,Adam S. Garden,Joshua B. Smith,Jack Phan,William H. Morrison,Stephen Y. Lai,Beth M. Beadle,Randal S. Weber,M.S. Kies,David I. Rosenthal,Clifton D. Fuller	2016	0
9	Complications, hospital length of stay, and readmission after total laryngectomy Cancer ·Ryan P. Goepfert,Katherine A. Hutcheson,Jan S. Lewin,Neha Desai,Mark Zafereo,Amy C. Hessel,Carol M. Lewis,Randal S. Weber,Neil D. Gross	2016	71
10	Novel MYBL1 Gene Rearrangements with Recurrent MYBL1–NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations Clinical Cancer Research ·Yoshitsugu Mitani,Bin Liu,Pulivarthi H. Rao,Vishnupriya J. Borra,Mark Zafereo,Randal S. Weber,Merrill S. Kies,Guillermina Lozano,P. Andrew Futreal,Carlos Caulı́n,Adel K. El‐Naggar	2015	154
11	Alterations Associated with Androgen Receptor Gene Activation in Salivary Duct Carcinoma of Both Sexes: Potential Therapeutic Ramifications Clinical Cancer Research ·Yoshitsugu Mitani,Pulivarthi H. Rao,Sankar N. Maity,Yu-Chen Lee,Renata Ferrarotto,Julian C. Post,Lisa Licitra,Scott M. Lippman,Merrill S. Kies,Randal S. Weber,Carlos Caulı́n,Sue-Hwa Lin,Adel K. El‐Naggar	2014	56
12	A Phase II Study of Gefitinib for Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck Clinical Cancer Research ·Carol M. Lewis,Bonnie S. Glisson,Lei Feng,Fiona Wan,Ximing Tang,Ignacio I. Wistuba,Adel K. El‐Naggar,David I. Rosenthal,Mark S. Chambers,Robert A. Lustig,Randal S. Weber	2012	131
13	DNA Repair Biomarker Profiling of Head and Neck Cancer: Ku80 Expression Predicts Locoregional Failure and Death following Radiotherapy Clinical Cancer Research ·Benjamin J. Moeller,John S. Yordy,Michelle D. Williams,Uma Giri,Uma Raju,David Molkentine,Lauren A. Byers,John V. Heymach,Michael D. Story,J. Jack Lee,Erich M. Sturgis,Randal S. Weber,Adam S. Garden,K. Kian Ang,David A. Schwartz	2011	75
14	Novel Chromosomal Rearrangements and Break Points at the t(6;9) in Salivary Adenoid Cystic Carcinoma: Association with MYB – NFIB Chimeric Fusion, MYB Expression, and Clinical Outcome Clinical Cancer Research ·Yoshitsugu Mitani,Pulivarthi H. Rao,P. Andrew Futreal,Dianna Roberts,Philip J. Stephens,Yi-Jue Zhao,Li Zhang,Mutsumi Mitani,Randal S. Weber,Scott M. Lippman,Carlos Caulı́n,Adel K. El‐Naggar	2011	116
15	Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic Significance Clinical Cancer Research ·Yoshitsugu Mitani,Jie Li,Pulivarthi H. Rao,Yi-Jue Zhao,Diana Bell,Scott M. Lippman,Randal S. Weber,Carlos Caulı́n,Adel K. El‐Naggar	2010	219
16	Genetic and Expression Analysis of HER-2 and EGFR Genes in Salivary Duct Carcinoma: Empirical and Therapeutic Significance Clinical Cancer Research ·Michelle D. Williams,Dianna Roberts,Merrill S. Kies,Li Mao,Randal S. Weber,Adel K. El‐Naggar	2010	99
17	Early Postoperative Paclitaxel Followed by Concurrent Paclitaxel and Cisplatin With Radiation Therapy for Patients With Resected High-Risk Head and Neck Squamous Cell Carcinoma: Report of the Phase II Trial RTOG 0024 Journal of Clinical Oncology ·David I. Rosenthal,Jonathan Harris,Arlene A. Forastiere,Randal S. Weber,John A. Ridge,Jeffrey N. Myers,Adam S. Garden,Michael Kuettel,K. Sidhu,Christopher J. Schultz,Andy Trotti,K. Kian Ang	2009	32
18	Concomitant Boost Radiation and Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Update of a Phase II Trial of the RTOG (99-14) International Journal of Radiation OncologyBiologyPhysics ·Adam S. Garden,Jonathan Harris,C. Jones,A. Trotti,Luis A. Carrascosa,J. Cheng,Sharon A. Spencer,Randal S. Weber,K. Kian Ang	2005	2
19	Early postoperative paclitaxel followed by paclitaxel and cisplatin concurrent with radiation therapy (RT) (phase II trial RTOG H-0024) is well tolerated for patients with resected, high-risk squamous carcinoma of the head and neck (HNSCC) International Journal of Radiation OncologyBiologyPhysics ·David I. Rosenthal,Jay R. Harris,Arlene A. Forastiere,Randal S. Weber,John A. Ridge,Jeffrey N. Myers,Adam S. Garden,Michael Kuettel,K. Sidhu,Christopher J. Schultz,K. Kian Ang	2004	2
20	Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal disease International Journal of Radiation OncologyBiologyPhysics ·Matthew T. Ballo,Gunar K. Zagars,J LEE,J MYERS,Edward M. Diaz,Erich M. Sturgis,Jeffrey E. Gershenwald,Merrick I. Ross,Randal S. Weber	2004	2

About Randal S. Weber

Randal S. Weber is a scholar working on Otorhinolaryngology, Oncology and Surgery, having authored 405 papers that have together received 28.7k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (195 papers), Salivary Gland Tumors Diagnosis and Treatment (86 papers), Head and Neck Surgical Oncology (78 papers), Ear and Head Tumors (67 papers), Cancer Diagnosis and Treatment (40 papers), Oral and Maxillofacial Pathology (34 papers), Tracheal and airway disorders (32 papers) and Nonmelanoma Skin Cancer Studies (31 papers). The work is most often cited by research in Otorhinolaryngology (16.1k citations), Oncology (10.1k citations) and Surgery (14.8k citations). Randal S. Weber has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include David I. Rosenthal, Adam S. Garden, K. Kian Ang, William H. Morrison, Adel K. El‐Naggar, Helmuth Goepfert, Arlene A. Forastiere, Jay S. Cooper, Jonathan Harris and Phuc Félix Nguyen‐Tan. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact